These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 16501580

  • 1. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms.
    Chang L, Luo L, Palmer JA, Sutton S, Wilson SJ, Barbier AJ, Breitenbucher JG, Chaplan SR, Webb M.
    Br J Pharmacol; 2006 May; 148(1):102-13. PubMed ID: 16501580
    [Abstract] [Full Text] [Related]

  • 2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG.
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [Abstract] [Full Text] [Related]

  • 3. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL, Stevens DL, Welch SP.
    Eur J Pharmacol; 2008 Dec 14; 600(1-3):50-8. PubMed ID: 18762181
    [Abstract] [Full Text] [Related]

  • 4. The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models.
    Caprioli A, Coccurello R, Rapino C, Di Serio S, Di Tommaso M, Vertechy M, Vacca V, Battista N, Pavone F, Maccarrone M, Borsini F.
    J Pharmacol Exp Ther; 2012 Jul 14; 342(1):188-95. PubMed ID: 22514334
    [Abstract] [Full Text] [Related]

  • 5. Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse.
    Palmer JA, Higuera ES, Chang L, Chaplan SR.
    Neuroscience; 2008 Jul 17; 154(4):1554-61. PubMed ID: 18541380
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
    Karbarz MJ, Luo L, Chang L, Tham CS, Palmer JA, Wilson SJ, Wennerholm ML, Brown SM, Scott BP, Apodaca RL, Keith JM, Wu J, Breitenbucher JG, Chaplan SR, Webb M.
    Anesth Analg; 2009 Jan 17; 108(1):316-29. PubMed ID: 19095868
    [Abstract] [Full Text] [Related]

  • 7. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Sep 17; 330(3):902-10. PubMed ID: 19502530
    [Abstract] [Full Text] [Related]

  • 8. Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.
    Hama AT, Germano P, Varghese MS, Cravatt BF, Milne GT, Pearson JP, Sagen J.
    PLoS One; 2014 Sep 17; 9(5):e96396. PubMed ID: 24788435
    [Abstract] [Full Text] [Related]

  • 9. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
    Booker L, Kinsey SG, Abdullah RA, Blankman JL, Long JZ, Ezzili C, Boger DL, Cravatt BF, Lichtman AH.
    Br J Pharmacol; 2012 Apr 17; 165(8):2485-96. PubMed ID: 21506952
    [Abstract] [Full Text] [Related]

  • 10. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain.
    Jhaveri MD, Richardson D, Kendall DA, Barrett DA, Chapman V.
    J Neurosci; 2006 Dec 20; 26(51):13318-27. PubMed ID: 17182782
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor.
    Watabiki T, Tsuji N, Kiso T, Ozawa T, Narazaki F, Kakimoto S.
    Eur J Pharmacol; 2017 Nov 15; 815():42-48. PubMed ID: 29017758
    [Abstract] [Full Text] [Related]

  • 12. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D.
    J Pharmacol Exp Ther; 2007 Jul 15; 322(1):236-42. PubMed ID: 17412883
    [Abstract] [Full Text] [Related]

  • 13. Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.
    Nasirinezhad F, Jergova S, Pearson JP, Sagen J.
    Neuropharmacology; 2015 Aug 15; 95():100-9. PubMed ID: 25486617
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C, Markert A, Zimmer A.
    Eur Neuropsychopharmacol; 2015 Aug 15; 25(8):1388-96. PubMed ID: 25910421
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
    Varvel SA, Wise LE, Niyuhire F, Cravatt BF, Lichtman AH.
    Neuropsychopharmacology; 2007 May 15; 32(5):1032-41. PubMed ID: 17047668
    [Abstract] [Full Text] [Related]

  • 16. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
    Naidu PS, Booker L, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Apr 15; 329(1):48-56. PubMed ID: 19118134
    [Abstract] [Full Text] [Related]

  • 17. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
    Maione S, Costa B, Piscitelli F, Morera E, De Chiaro M, Comelli F, Boccella S, Guida F, Verde R, Ortar G, Di Marzo V.
    Pharmacol Res; 2013 Oct 15; 76():98-105. PubMed ID: 23911581
    [Abstract] [Full Text] [Related]

  • 18. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M, Tanda G, Justinova Z, Wertheim CE, Yasar S, Piomelli D, Vadivel SK, Makriyannis A, Goldberg SR.
    J Pharmacol Exp Ther; 2007 Apr 15; 321(1):370-80. PubMed ID: 17210800
    [Abstract] [Full Text] [Related]

  • 19. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.
    Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW.
    Br J Pharmacol; 2006 Feb 15; 147(3):281-8. PubMed ID: 16331291
    [Abstract] [Full Text] [Related]

  • 20. ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain.
    Kiso T, Watabiki T, Sekizawa T.
    Eur J Pharmacol; 2020 Aug 15; 881():173194. PubMed ID: 32445705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.